How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study

Ewoud Schuit; Alvin H. Li; John P A Ioannidis

doi:10.1093/ije/dyy239

Abstract

1 min read

Availability of individual-level data provides statistically significant interactions for relative treatment effects in about a third of IPDMAs. A modest number of these interactions may offer opportunities for stratified medicine decisions.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Preprint2024

Evaluation of reported claims of sex-based differences in treatment effects across meta-analyses: A meta-research study

Lum Kastrati, Sara Farina, Angelica Valz Gris, Hamidreza Raeisi‐Dehkordi, Erand Llanaj, Hugo G. Quezada‐Pinedo, Lia Bally, Taulant Muka, John P A Ioannidis

Editorial Material2017

Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews

John P A Ioannidis

Article2025

Evaluation of reported claims of sex-based differences in treatment effects across meta-analyses: a meta-research study

Lum Kastrati, Sara Farina, Angelica Valz Gris, Hamidreza Raeisi‐Dehkordi, Erand Llanaj, Hugo G. Quezada‐Pinedo, Lia Bally, Taulant Muka, John P A Ioannidis

Article2022

Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data

Xiaoting Shi, Haoran Zhuo, Yuxuan Du, Kate Nyhan, John P A Ioannidis, Joshua D. Wallach

Article2019

Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study

Patrick Liu, John P A Ioannidis, Joseph S. Ross, Sanket S. Dhruva, Anita T. Luxkaranayagam, Vasilis S. Vasiliou, Joshua D. Wallach